SEC reporting owner
| Reporting owner CIK | 0001734779 |
|---|---|
| Issuers | 5 |
| Qualifying disclosures | 22 |
| Public purchases | 0 |
| Recent-window purchases | 0 |
| Recent-window sales | 7 |
| Last public filing | 2026-04-25 |
| Coverage | verified |
| Directory rank | 19,921 |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-04-24 | 2026-04-23 | PCRX | S | 12,941 | Not reported |
| 2026-04-22 | 2026-04-22 | PCRX | S | 1,500 | Not reported |
| 2026-04-22 | 2026-04-21 | PCRX | S | 2,845 | Not reported |
| 2026-04-22 | 2026-04-20 | PCRX | S | 7,714 | Not reported |
| 2026-02-13 | 2026-02-11 | PCRX | A | 49,091 | Not reported |
| 2025-12-11 | 2025-12-10 | PCRX | S | 9,104 | Not reported |
| 2025-12-11 | 2025-12-09 | PCRX | S | 15,896 | Not reported |
| 2025-11-13 | 2025-11-10 | PCRX | S | 12,060 | Not reported |
| 2025-03-03 | 2025-02-27 | CYTH | A | 28,597 | Not reported |
| 2024-11-18 | 2024-11-15 | CYTH | A | 17,228 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.